Cantitate/Preț
Produs

The Long Shot

Autor Kate Bingham, Tim Hames
en Limba Engleză Hardback – 19 oct 2022
How Covid-19 vaccines went from the laboratory to people’s arms – the inside story of an extraordinary national campaign against all odds

The Times bestseller

FT Book of the Year

On 3 April 2020, Kate Bingham was told that the likelihood of any Covid-19 vaccine working was 15% at best. But on 8 December 2020, the first NHS patient received a vaccine. Now nearly every adult in Britain has had a jab, lockdowns have ended and we can finally live with Covid. What lies behind this staggering success story?

From a cottage miles away from Westminster, Bingham juggled vaccine suppliers, Whitehall, the media circus – and her daughter’s exams. Political manoeuvring, miscommunications and administrative meddling nearly jeopardised the project. But perseverance paid off.

Catapulted into a national crisis, Bingham’s eclectic team secured the first vaccine doses administered in the West and saved thousands of lives in the UK as new variants struck. This is an unmissable insider view into how the Vaccine Taskforce beat the odds and delivered the scientific miracle we all waited for.
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 7060 lei  3-5 săpt. +1268 lei  10-14 zile
  Oneworld Publications – 4 oct 2023 7060 lei  3-5 săpt. +1268 lei  10-14 zile
Hardback (1) 12210 lei  3-5 săpt. +2242 lei  10-14 zile
  Oneworld Publications – 19 oct 2022 12210 lei  3-5 săpt. +2242 lei  10-14 zile

Preț: 12210 lei

Nou

Puncte Express: 183

Preț estimativ în valută:
2337 2436$ 1945£

Carte disponibilă

Livrare economică 14-28 decembrie
Livrare express 03-07 decembrie pentru 3241 lei

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9780861545643
ISBN-10: 0861545648
Pagini: 336
Dimensiuni: 157 x 238 x 32 mm
Greutate: 0.54 kg
Editura: Oneworld Publications

Notă biografică

Dame Kate Bingham served as the Chair of the UK Vaccine Taskforce, on a seven-month unpaid secondment, steering a team of experts to deliver the world¿s fastest Covid-19 vaccination programme. She is Managing Partner at life sciences venture capital firm SV Health Investors where she co-leads SV¿s biotech franchise which has a long history of developing transformational new medicines. She was awarded a DBE for her services as Chair of the UK Vaccine Taskforce.